✦ LIBER ✦

Optimizing target-organ protection in patients with diabetes mellitus: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers?

✍ Scribed by Wei X. Lu; Jay Lakkis; Matthew R. Weir

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiotensin converting enzyme inhibitors

✍ Jay Garg; George L. Bakris 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 311 KB

Angiotensin converting enzyme inhibitor

✍ Ching-Chu Chen; An-Na Chiang; Min-Huang Hsieh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Angiotensin-Converting Enzyme Inhibitors

✍ Vasilios Papademetriou; Puneet Narayan; Peter Kokkinos 📂 Article 📅 2004 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 376 KB

PDB12 Comparative Effectiveness Study of

✍ H.M. Campbell; N. Khan; D.W. Raisch; M. Borrego; M. Sather; G.H. Murata 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

CAN ANGIOTENSIN-CONVERTING ENZYME INHIBI

✍ Santosh B. Murthy; Ali Jawaid; Shreyansh Shah; Salah U. Qureshi; Paul E. Schulz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Prognostic Impact of Angiotensin-convert

✍ Jun Takahashi; Nobuyuki Shiba; Tomohiro Tada; Hiroaki Shimokawa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 127 KB